Yekaterina Chudnovsky - 19 Mar 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director, 10%+ Owner
Signature
/s/ Yekaterina Chudnovsky
Issuer symbol
ELTX
Transactions as of
19 Mar 2024
Net transactions value
+$5,999,999
Form type
4
Filing time
20 Mar 2024, 16:28:11 UTC
Previous filing
29 Dec 2023
Next filing
27 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Pre-Funded Common Stock Purchase Warrant Purchase $5,999,999 +1,032,702 $5.81 1,032,702 19 Mar 2024 Common Stock 1,032,702 $0.0100 Held by GKCC, LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained.
F2 The Pre-Funded Warrants do not have an expiration date.
F3 Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.